Company / Current Liabilities per Share
Halozyme Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.44
FY2025
5-year range
$0.83 / $1.44
FY2021-FY2025
Trend
+31.1%
vs FY2024
Sector context
#93 of 210
Health Care
What the data says
At $1.44, Halozyme's current liabilities per share ranks #118 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.43 in FY2016 to $3.08 in FY2020.
Based on SEC 10-K filings.
1.44 in FY2025 with a 5-year CAGR of -14.1%.
Increased from $0.83 to $1.44 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +14.8%
- 5-Year CAGR
- -14.1%
- 10-Year CAGR
- -
Sector benchmark
#118 of 210 in Health CareTop 56% of 210This company $1.44 Sector average $15.78
▼
-90.9% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 31.1% year-over-year.
- Ranks #93 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 47.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 118.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.44 | +31.1% |
| FY2024 | $1.10 | +31.8% |
| FY2023 | $0.83 | -12.5% |
| FY2022 | $0.95 | +9.6% |
| FY2021 | $0.87 | -71.9% |
| FY2020 | $3.08 | +420.9% |
| FY2019 | $0.59 | -43.4% |
| FY2018 | $1.05 | +3.1% |
| FY2017 | $1.01 | +138.1% |
| FY2016 | $0.43 | -14.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026